Mary Anne Heino
President and Chief Executive Officer
Mary Anne Heino brings to Lantheus more than 25 years of diverse pharmaceutical industry experience. Joining Lantheus in April 2013 as Chief Commercial Officer, Ms. Heino was promoted to Chief Operating Officer in March 2015 and to President and Chief Executive Officer in August 2015. Prior to joining Lantheus, Ms. Heino led Angelini Labopharm LLC and Labopharm USA in the roles of President and Senior Vice President of World Wide Sales and Marketing. Before that, Ms. Heino served in numerous capacities at Centocor, Inc., a Johnson & Johnson Company, including Vice President Strategic Planning and Competitive Intelligence, Vice President Sales, Executive Director Customer Relationship Management and Senior Director Immunology Marketing. Ms. Heino began her professional career with Janssen Pharmaceutica as a Sales Representative in June 1989 and worked her way up to the role of Field Sales Director in 1999. Ms. Heino received her Master’s in Business Administration from the Stern School of Business at New York University. She earned a Bachelor’s of Science in Nursing from the City University of New York and a Bachelor’s of Science in Biology from the State University of New York at Stony Brook.
Senior Vice President, Technical Operations
John Bolla joined Lantheus as Senior Vice President of Technical Operations in May 2018. In this role, he is responsible for leading the company’s Supply Chain, Manufacturing, Operations, Engineering and Facilities Functions. He brings to the role more than 22 years of diverse supply chain, operations and manufacturing experience in the pharmaceutical industry.
Prior to joining Lantheus, Mr. Bolla spent 20 years at GlaxoSmithKline plc (GSK), a global branded pharmaceutical company. He held various senior leadership roles, including Vice President, Supply Chain, North America, where he was responsible for leading all manufacturing, supply planning, logistics and distribution for GSK’s largest global market. He also held senior roles as Vice President and Site General Manager for a large GSK manufacturing facility in the U.S. as well as Vice President and Global Head of External Supply and Global Contract Manufacturing. He has also served in multiple senior Procurement leadership roles at GSK.
Mr. Bolla holds a Bachelor of Science in Business Administration/Accounting from The University of Central Florida.
Chief Financial Officer
Jack Crowley serves as the Company’s Chief Financial Officer. He brings to the role more than 28 years of financial management and accounting experience. He previously served as interim Chief Financial Officer from December 2015 until March 2016. Prior to that, he held the roles of Vice President, Chief Accounting Officer from March 2015 to December 2015, Vice President, Finance from April 2013 until March 2015, and was Director, Accounting from September 2010 until April 2013.
Prior to joining Lantheus, Mr. Crowley served in the roles of Assistant Corporate Controller, and prior to that, Director of Finance at Biogen Idec. Mr. Crowley also previously served as Director of Accounting at Fisher Scientific International. Prior to Fisher, Mr. Crowley was a Senior Audit Manager in the Technology practice of PriceWaterhouseCoopers. Mr. Crowley holds a Master of Business Administration from the University of Massachusetts and a Bachelor of Science in Business Administration from Westfield State University, and is a Certified Public Accountant.
Senior Vice President - Law and Public Policy, General Counsel and Secretary
Michael (Mike) Duffy joined Lantheus as Vice President, General Counsel and Secretary in 2008. Prior to joining Lantheus, he served as Senior Vice President, General Counsel and Secretary of Point Therapeutics, Inc., a Boston-based biopharmaceutical company. He has also served as General Counsel and in other leadership positions for several technology companies in the Boston area and in Washington, D.C. Mike began his legal career with Ropes & Gray in Boston and holds law degrees from the University of Pennsylvania and Oxford University and an undergraduate degree from Harvard College.
Sarah Le Roy
Senior Vice President, Human Resources
Sarah Le Roy has served as Senior Vice President, Human Resources since April 2018. She joined Lantheus in January 2018 as Vice President, Human Resources. She brings to the company more than 20 years of experience serving as a results-focused Human Resources leader for global companies across a variety of industries. Sarah most recently served as Executive Vice President Organizational Strategy for Fike Corporation, a privately held, globally recognized supplier of products and services that protect people and critical assets from dangers such as fire and explosion, where she was responsible for leading all Human Resources, Legal, and Corporate Communications activities across the globe. Prior to that, Sarah worked as Vice President, Talent Management, Head of Talent and Assessment Practices and Co-Head of the High Performance Team Practice for Linkage, Inc., a global organizational development company. Earlier in her career, she held a variety of Human Resources, organizational learning, executive search and recruiting positions. Sarah received an MBA/MSC in Business from the MIT Sloan School of Management and a Bachelor of Arts from Williams College.
Cesare Orlandi, MD
Chief Medical Officer
Dr. Cesare (Ces) Orlandi joined Lantheus in March 2013 as Chief Medical Officer. Ces brings to the company more than 20 years of diverse pharmaceutical industry experience with a proven track record of directing successful drug development programs, providing leadership in product pipeline portfolio management and overseeing interactions with regulatory agencies. Ces most recently served as Senior Vice President and Chief Medical Officer of TransTech Pharma, Inc., a clinical-stage pharmaceutical company, where he led drug development from Phase 1 through Phase 3 trials for the company’s pipeline programs. Prior to joining TransTech, Ces served as the Senior Vice President and Chief Medical Officer of Cardiokine, Inc., a specialty pharmaceutical company, completing the late stage development of lixivaptan, a Phase 3 program in 20 countries and over 500 sites worldwide. Earlier in his career, he worked with Otsuka Pharmaceuticals, Medco Research Inc. and the Radiopharmaceutical Division of Du Pont Merck Pharmaceutical Company, which is now Lantheus Medical Imaging. Ces received his medical degree with honors from the University of Pavia Medical School, Pavia, Italy. He is currently an Adjunct Assistant Professor of Medicine at Tufts University School of Medicine, Boston.
Simon Robinson, Ph.D.
Senior Vice President, Research and Pharmaceutical Development
Simon Robinson has served as Senior Vice President, Research and Pharmaceutical Development since April 2018. He previously served as Vice President, Research and Pharmaceutical Development from 2010 to 2018. Prior to that, he served as Senior Director, Discovery Research from 2008 to 2010 and Director, Discovery Biology and Veterinary Sciences from 2001 to 2008. Before joining Lantheus, he held research positions at Bristol-Myers Squibb, Sphinx Pharmaceuticals, BASF and DuPont Pharmaceuticals. Simon has more than 80 publications and is listed as an inventor on 19 U.S. patents. He holds a Ph.D. and Bachelor of Science Pharmacology from the University of Leeds, England and performed his post-doctoral training at the University of Wisconsin Clinical Cancer Center.
Senior Vice President, Quality
Carol Walker has served as Senior Vice President, Quality since April 2018. She has overseen our Environment, Health and Safety department since December 2017. She joined Lantheus in February 2015 as Vice President, Quality. Carol brings more than 30 years of industry experience in quality and medical technology primarily in the medical device area. Prior to joining Lantheus, she served as Vice President of Quality Assurance and Regulatory Affairs for Intelligent Medical Devices, Inc. (IMDx), a company that designs, develops and manufactures in vitro diagnostic devices. Prior to that, Carol spent 11 years with Siemens Healthcare Diagnostics where she held positions of increasing responsibility, including Vice President of Quality Assurance. Earlier in her career, Carol held a variety of quality control positions during her 15 year tenure with Nova Biomedical, one of the 25 largest in vitro diagnostic companies in the world. Carol received a Bachelor of Science in Medical Technology from the Rochester Institute of Technology.